Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Eastman Kodak Co. (KODK)
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-05
$7.40-1.46%
Close 2026-11-05 · 1-day change
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.78 → 0.78 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for KODK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
maintain manageable financial risk | A supporting condition in Eastman Kodak Co.'s published investment case. The stated target is no significant increase in leverage or liquidity issues. | Intact | significant deterioration in leverage or liquidity | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, cyclical business with signs of an operating improvement, rather than a steady compounder. The thesis is on watch: recent results show progress, but performance remains below its industry cohort and the evidence is only moderately confident.
The valuation evidence is mixed: KODK is described as cheap versus peers, while a separate measure shows a 47% premium to peers. The model has low confidence, and its expectations-gap measure is negative; the snapshot does not define its scale, so what the market assumes is unclear. Overall, the priced-in assessment is tagged as justified, with low fragility.
Near term, revenue and gross profit growth and higher Operational EBITDA show management priorities translating into results. But cash declined as the company repaid debt and increased inventory, and a run of recent earnings misses points to elevated risk of another near-term miss. Over the multi-year view, execution and cash-flow management remain central, while the industrial-sector backdrop is a headwind.
The favorable case depends in part on industrial bellwethers continuing to report strong results and raise guidance, sustaining sector momentum. The unfavorable case includes those companies missing or lowering guidance, or continued weakening in jobs data that increases recession concerns for cyclical businesses. KODK’s own earnings consistency and ability to strengthen its balance sheet are also key swing factors.
Over the next 1 to 3 years, KODK shows operational progress, but its long-term thesis remains uncertain because earnings quality is fragile, risk is high, and cash progress is mixed. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Eastman Kodak Co.'s published investment case. The stated target is acquisitions contribute positively to revenue and margins. |
| Intact |
| acquisitions fail to improve revenue or margins |
Q3 rev $276M (missed by $18.3M); Q2 rev +18% YoY Q2 revenue up 18% YoY; Q3 results stronger; AMC acquisition cited as growth engine. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
return to profitability | A primary condition in Eastman Kodak Co.'s published investment case. The stated target is positive net income. | Improving | net income remains negative beyond next 4 quarters | Net income: $21M FY2026-Q3; GAAP. Published target: positive net income. Target period is not explicitly aligned with this observation. Nov 3, 202621,000,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
annual revenue growth | A primary condition in Eastman Kodak Co.'s published investment case. The stated target is >=1% YoY. | Intact | annual revenue growth falls below 0% | Revenue growth: 2.6% FY2026-Q3; GAAP. Published target: >=1% YoY. Target period is not explicitly aligned with this observation. Nov 3, 20262.60223 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.78 → $0.78 · observed estimates
$1.26B → $1.26B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-17 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-18 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-19 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-20 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-21 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-22 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-23 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-24 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-25 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-26 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-27 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-28 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-29 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-09-30 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-01 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-02 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-03 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-04 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-05 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-06 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-07 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-08 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-09 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-10 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-11 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-12 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-13 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-14 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-15 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-16 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-17 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-18 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-19 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-20 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-21 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-22 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-23 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-24 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-25 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-26 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-27 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-28 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-29 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-30 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-10-31 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-11-01 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-11-02 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-11-03 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-11-04 | $0.78 | $1,261,000,000 | 1 / 1 |
| 2026-11-05 | $0.78 | $1,261,000,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.